Esperion Therapeutics, Inc. Announces Pricing of Initial Public Offering by longitudeadmin | Jun 26, 2013 | Portfolio News
Rapid Micro Biosystems Secures $32.6 Million in Series B Financing by longitudeadmin | Jun 26, 2013 | Portfolio News
Fraxel® Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation by longitudeadmin | Jun 20, 2013 | Portfolio News
Amarin Informed by FDA of October 16th Advisory Committee Date in Connection With Supplemental New Drug Application (sNDA) for Vascepa(R) in the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidemia by longitudeadmin | Jun 19, 2013 | Portfolio News
Civitas Therapeutics Receives Second Grant for Their Lead Product CVT-301 from The Michael J. Fox Foundation for Parkinson’s Research by longitudeadmin | Jun 18, 2013 | Portfolio News
